Thiamine: Difference between revisions
3amrbadawy (talk | contribs) No edit summary |
3amrbadawy (talk | contribs) No edit summary |
||
| Line 39: | Line 39: | ||
===Common=== | ===Common=== | ||
*injection site pain | |||
*pruritus | |||
*warmth sensation | |||
*urticaria | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 18:12, 15 February 2016
Administration
- Dosage Forms: 50,100,250,500mg
- Routes of Administration: IM, IV
- Im or IV routres require: Intradermal skin test before use if hypersensitivity risk
- Common Trade Names: Vitamin B1
Adult Dosing
- Beriberi
- 10-20 mg IM tid x 2wk
- Then 5-30 mg PO qd x1mo
- 10-20 mg IM tid x 2wk
- Wet beriberi w/ CHF
- 10-30 mg IV tid
- Wernicke encephalopathy
- 100 mg IV x1
- Then 50-100 mg IM/IV qd
- 100 mg IV x1
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- anaphylaxis
- angioedema
- cyanosis
Common
- injection site pain
- pruritus
- warmth sensation
- urticaria
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
